<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>EN SyntheticMR BLOG</title>
    <link>https://blog.syntheticmr.com</link>
    <description>Blog´s SyntheticMR</description>
    <language>en</language>
    <pubDate>Thu, 20 Aug 2026 03:33:45 GMT</pubDate>
    <dc:date>2026-08-20T03:33:45Z</dc:date>
    <dc:language>en</dc:language>
    <item>
      <title>The Growing Role of Quantitative PET Imaging in Alzheimer’s Disease</title>
      <link>https://blog.syntheticmr.com/the-growing-role-of-quantitative-pet-imaging-in-alzheimers-disease</link>
      <description>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="https://blog.syntheticmr.com/the-growing-role-of-quantitative-pet-imaging-in-alzheimers-disease" title="" class="hs-featured-image-link"&gt; &lt;img src="https://blog.syntheticmr.com/hubfs/AdobeStock_328872330.jpg" alt="The Growing Role of Quantitative PET Imaging in Alzheimer’s Disease" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;h2&gt;&lt;strong&gt;Why PET quantification matters today&lt;/strong&gt;&lt;/h2&gt; 
&lt;p&gt;The treatment landscape for Alzheimer’s disease is changing. With the introduction of disease-modifying anti-amyloid therapies, clinicians need reliable ways to identify the right patients, measure amyloid burden, and monitor changes over time. While PET scans have long been used to detect amyloid plaques in the brain, visual interpretation alone can vary between readers, making objective quantification increasingly valuable.&lt;/p&gt;</description>
      <content:encoded>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="https://blog.syntheticmr.com/the-growing-role-of-quantitative-pet-imaging-in-alzheimers-disease" title="" class="hs-featured-image-link"&gt; &lt;img src="https://blog.syntheticmr.com/hubfs/AdobeStock_328872330.jpg" alt="The Growing Role of Quantitative PET Imaging in Alzheimer’s Disease" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;h2&gt;&lt;strong&gt;Why PET quantification matters today&lt;/strong&gt;&lt;/h2&gt; 
&lt;p&gt;The treatment landscape for Alzheimer’s disease is changing. With the introduction of disease-modifying anti-amyloid therapies, clinicians need reliable ways to identify the right patients, measure amyloid burden, and monitor changes over time. While PET scans have long been used to detect amyloid plaques in the brain, visual interpretation alone can vary between readers, making objective quantification increasingly valuable.&lt;/p&gt;  
&lt;img src="https://track-eu1.hubspot.com/__ptq.gif?a=25347468&amp;amp;k=14&amp;amp;r=https%3A%2F%2Fblog.syntheticmr.com%2Fthe-growing-role-of-quantitative-pet-imaging-in-alzheimers-disease&amp;amp;bu=https%253A%252F%252Fblog.syntheticmr.com&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <category>qMRI for Neuroimaging</category>
      <category>AI for Neuroimaging</category>
      <category>Quantitative PET Imaging</category>
      <category>Centiloid Quantification</category>
      <category>Nuclear Medicine</category>
      <category>Alzheimer’s Disease</category>
      <category>Treatment Monitoring</category>
      <category>cPET</category>
      <category>Combinostics</category>
      <category>Amyloid PET</category>
      <pubDate>Fri, 14 Aug 2026 19:20:25 GMT</pubDate>
      <guid>https://blog.syntheticmr.com/the-growing-role-of-quantitative-pet-imaging-in-alzheimers-disease</guid>
      <dc:date>2026-08-14T19:20:25Z</dc:date>
      <dc:creator>Elena Bonke</dc:creator>
    </item>
  </channel>
</rss>
